Trader consensus on Polymarket implies an 88.5% probability of no new pandemic in 2026, reflecting the absence of any novel pathogen exhibiting sustained human-to-human transmission required for WHO pandemic declaration, as per official surveillance from WHO, CDC, and ECDC. Recent ECDC Communicable Disease Threats Reports (April 4–10) highlight localized concerns like avian influenza A(H5N1) sporadic cases and measles outbreaks linked to vaccine hesitancy—1,704 U.S. cases by early April, 94% outbreak-associated—but none show global epidemic potential or novel emergence. Global monitoring networks report no escalating zoonotic spillovers, with seasonal influenza and dengue contained regionally. While inherent uncertainties in pathogen evolution persist, baseline historical rarity (last pandemic: COVID-19, 2020) and strong early detection systems underpin this positioning, with weekly updates from agencies poised to flag shifts.